#United States #San Francisco #J.P. Morgan #Italian Trade Agency #Italy on the Move

Italy on the Move 2025: A Golden Opportunity for Investors

Event Overview
On January 15, 2025, the Italian Trade Agency (ITA) and the Italian Ministry of Foreign Affairs will host the eighth edition of "Italy on the Move," coinciding with the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. This prominent event will focus on showcasing Italy as a leading hub for investment in biotechnology, healthcare, medical devices, and pharmaceuticals. The meeting is to take place at INNOVIT, also known as San Francisco's Italian Innovation and Culture Hub, located at 710 Sansome Street.

A Platform for Growth
Opening remarks will be delivered by Italy's Ambassador to the U.S., H.E. Mariangela Zappia, alongside Consul General Sergio Strozzi. The keynote address will be provided by Mauro Battocchi, the Director General for the Promotion of the Italy System at the Ministry of Foreign Affairs, who will outline the potential of Italy's life sciences sector—valued at €270 billion and constituting 11% of the country's GDP. Battocchi emphasizes that Italy's robust pharmaceutical, biotech, and medical devices industries have attracted numerous multinationals, presenting significant opportunities for growth and collaboration in the sector.

Building Partnerships
Ambassador Zappia highlighted Italy's life sciences as a fast-evolving field that outpaces traditional exports like fashion and wine. The event presents an unparalleled opportunity for U.S. healthcare companies and investors to engage with Italian firms, forming potential partnerships that could unlock new avenues for growth. Consul General Strozzi reiterated that Italy is a leader in pharmaceutical manufacturing within the European Union and ranks highly in patent productivity worldwide, making it an attractive destination for investment.

Engaging Discussions and Pitches
The event's agenda includes a panel discussion titled "Navigating Transatlantic Partnerships in Life Sciences," moderated by Audrey Greenberg, founder of the Center for Breakthrough Medicines. This panel will feature esteemed executives from notable firms such as Rubedo Life Sciences and Menarini Group, highlighting successful collaborations and sharing insights on the international life sciences landscape. Additionally, five outstanding Italian startups—Aavantgarde, Butterfly Decisions, Cellply, Medlea, and Sibylla Biotech—will participate in dedicated pitch presentations, showcasing their innovative solutions to a global audience.

Conclusion
Since its inception in 2016, "Italy on the Move" has positioned itself as a crucial event for the Italian life sciences sector in the U.S., bringing together industry leaders and fostering international cooperation. As the 2025 edition approaches, excitement builds around the potential it holds for enhancing collaborations and investment opportunities in a sector poised for further expansion.

For more information on the event, visit the Italian Trade Agency website and the INNOVIT website.